IRCON's Q1FY27 consolidated revenue grew 9.5% YoY to ₹1,956 Cr, though PAT fell 43.9% due to margin contraction. Strategy focuses on Navratna status and Railway/Highway infrastructure projects.
KD Green Industries will invest up to ₹15 Crore in its subsidiary, K D Infrastructures, through a fresh capital subscription. This funding supports the subsidiary's operational needs.
JSW Dulux Limited has updated its official website and domain name to www.jswdulux.com, with automatic redirection implemented from the previous domain for stakeholder convenience.
Hindustan Oil Exploration Company Legal & Regulatory
The Board noted and paid a ₹0.0059 Crore fine imposed by stock exchanges for a delay in submitting financial results for the year ended March 31, 2026.
B.A.G. Convergence Limited announced its 19th Annual General Meeting, scheduled for September 24, 2026, through video conferencing, along with the associated book closure dates.
R K Swamy reported solid Q1 FY27 results with consolidated income and PBT growth, focusing on margin expansion through operating leverage and new high-value consulting and digital content streams.
Management is pivoting to acquisitions after regulatory shifts blocked organic expansion in Hyderabad. While revenue growth appears strong due to the Numed consolidation, margins were hurt by high logistics costs in Australia.
Rajputana Stainless Limited has re-appointed its Statutory, Secretarial, Cost, and Internal Auditors. These routine professional appointments follow standard corporate governance practices.
Ester Industries delivered a strong turnaround in Q1 FY27, with consolidated revenue rising 27% and PAT turning positive at ₹18.6 crore, driven by improved business mix and realizations.
Shringar House of Mangalsutra Limited reports strong Q1 FY27 results with 65% revenue growth YoY, driven by increasing sales to corporate clients and expanded manufacturing capacity.
Q1 FY27 saw consolidated revenue of Rs. 1,465 cr and PAT of Rs. 48.4 cr. Domestic demand remains soft, but management is focused on structural cost optimization and international expansion.
Nephrocare delivered robust 23.7% revenue growth driven by international expansion and volume gains. While margins improved via operating leverage, high working capital cycles and binary outcomes in tender markets like Saudi Arabia remain key risks.